CDK5 and cancer: Since the research results on inhibitors of CDK5 have been conducted to develop therapeutics for neurological diseases, if these results can be used to develop therapeutics for various cancers, it is expected to create a specific inhibitor for CDK5 at a relatively rapid pace.